Skip to content

A randomized, double-blind, prospective, controlled trial for Yishen-Tongbi-Tang in the treatment of active rheumatoid arthritis

A randomized, double-blind, prospective, controlled trial for Yishen-Tongbi-Tang in the treatment of active rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024902
Enrollment
Unknown
Registered
2019-08-03
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the 2010 European League Against Rheumatism and the American College of Rheumatology RA classification criteria and have a RA course of at least 6 weeks; 2. Aged 18-65 years old; 3. AT least three swollen joints (SJC) and five tender joints (TJC); 4. Erythrocyte sedimentation rate (ESR)>28mm/h or C-reactive protein (CRP)>20mg/L; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. pregnant or lactating women; 2. There are fertility requirements at present and in the future; 3. History of chronic severe infection, any current infection and any malignant tumor; 4. Patients with severe primary diseases and mental illnesses such as cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems; 5. Those with a history of drug allergy; 6. Using disease-modifying anti-rheumatic drugs (DMARDs) and biological disease-modifying anti-rheumatic drugs within the first 3 months of enrollment; 7. The investigator believes that it is not appropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
CDAI;SDAI;

Secondary

MeasureTime frame
DAS28;ACR20;ACR50;ACR70;

Countries

China

Contacts

Public ContactGuangxing Chen

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

cgx02@hotmail.com+86 13711602757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026